NURS 6630 FINAL EXAM QUESTIONS
WITH CORRECT DETAILED SOLUTIONS
2026/2027 LATEST UPDATE WALDEN
UNIVERSITY.
• Question 11
0 out of 1 points
A 63-year-old patient presents with the following symptoms. The PMHNP
determines which set of symptoms warrant prescribing a medication? Select the
answer that is matched with an appropriate treatment.
Selected C.
Answer: Reduced ability to find the correct word is most problematic, and an
appropriate treatment option would be memantine.
• Question 12
1 out of 1 points The PMHNP is caring for a patient who openly admitted to
drinking a quart of vodka daily. Prior to prescribing this patient disulfiram
(Antabuse), it is important for the PMHNP to:
Page 1 of 32
, Selected A.
Answer: Evaluate the patient’s willingness to abstain from alcohol
• Question 13
0 out of 1 points
A PMHNP supervisor is discussing with a nursing student how stimulants
and noradrenergic agents assist with ADHD symptoms. What is the appropriate
response?
Selected Answer: A.
They both increase signal strength output dopamine (DA) and norepinephrine
(NE).
• Question 14
1 out of 1 points
The PMHNP is assessing a female patient who has been taking lamotrigine
(Lamictal) for migraine prophylaxis. After discovering that the patient has
reached the maximum dose of this medication, the PMHNP decides to change
the patient’s medication to zonisamide
(Zonegran). In addition to evaluating this patient’s day-to-day activities, what
should the PMHNP ensure that this patient understands?
Page 2 of 32
, Selected D.
Answer: This medication has unwanted side effects such as sedation, lack of
coordination, and drowsiness.
• Question 15
0 out of 0 points
When completing this exam, did you comply with Walden University’s Code of
Conduct including the expectations for academic integrity?
Selected Answer: Yes
• Question 16
1 out of 1 points The PMHNP is teaching a patient with a sleep disorder about
taking diphenhydramine (Benadryl). The patient is concerned about the side
effects of the drug. What can the PMHNP teach the patient about this treatment
approach?
Selected Answer: B.
“It can cause blurred vision.”
• Question 17
1 out of 1 points The PMHNP is performing a quality assurance peer review of
the chart of another PMHNP. Upon review, the PMHNP reviews the chart of an
older adult patient in long-term care facility who has chronic insomnia. The
Page 3 of 32
, chart indicates that the patient has been receiving hypnotics on a nightly basis.
What does the PMHNP find problematic about this documentation?
Selected B.
Answer: Hypnotics have prolonged half-lives that can cause drug
accumulation in the elderly.
• Question 18
1 out of 1 points
A 14-year-old patient is prescribed Strattera and asks when the medicine
should be taken. What does the PMHNP understand regarding the drug’s dosing
profile?
Selected Answer: B.
The patient will have one or two doses a day.
• Question 19
1 out of 1 points The PMHNP is assessing a patient who presents with elevated
levels of brain amyloid as noted by positron emission tomography (PET). What
other factors will the PMHNP consider before prescribing medication for this
patient, and what medication would the PMHNP want to avoid given these
other factors?
Page 4 of 32
WITH CORRECT DETAILED SOLUTIONS
2026/2027 LATEST UPDATE WALDEN
UNIVERSITY.
• Question 11
0 out of 1 points
A 63-year-old patient presents with the following symptoms. The PMHNP
determines which set of symptoms warrant prescribing a medication? Select the
answer that is matched with an appropriate treatment.
Selected C.
Answer: Reduced ability to find the correct word is most problematic, and an
appropriate treatment option would be memantine.
• Question 12
1 out of 1 points The PMHNP is caring for a patient who openly admitted to
drinking a quart of vodka daily. Prior to prescribing this patient disulfiram
(Antabuse), it is important for the PMHNP to:
Page 1 of 32
, Selected A.
Answer: Evaluate the patient’s willingness to abstain from alcohol
• Question 13
0 out of 1 points
A PMHNP supervisor is discussing with a nursing student how stimulants
and noradrenergic agents assist with ADHD symptoms. What is the appropriate
response?
Selected Answer: A.
They both increase signal strength output dopamine (DA) and norepinephrine
(NE).
• Question 14
1 out of 1 points
The PMHNP is assessing a female patient who has been taking lamotrigine
(Lamictal) for migraine prophylaxis. After discovering that the patient has
reached the maximum dose of this medication, the PMHNP decides to change
the patient’s medication to zonisamide
(Zonegran). In addition to evaluating this patient’s day-to-day activities, what
should the PMHNP ensure that this patient understands?
Page 2 of 32
, Selected D.
Answer: This medication has unwanted side effects such as sedation, lack of
coordination, and drowsiness.
• Question 15
0 out of 0 points
When completing this exam, did you comply with Walden University’s Code of
Conduct including the expectations for academic integrity?
Selected Answer: Yes
• Question 16
1 out of 1 points The PMHNP is teaching a patient with a sleep disorder about
taking diphenhydramine (Benadryl). The patient is concerned about the side
effects of the drug. What can the PMHNP teach the patient about this treatment
approach?
Selected Answer: B.
“It can cause blurred vision.”
• Question 17
1 out of 1 points The PMHNP is performing a quality assurance peer review of
the chart of another PMHNP. Upon review, the PMHNP reviews the chart of an
older adult patient in long-term care facility who has chronic insomnia. The
Page 3 of 32
, chart indicates that the patient has been receiving hypnotics on a nightly basis.
What does the PMHNP find problematic about this documentation?
Selected B.
Answer: Hypnotics have prolonged half-lives that can cause drug
accumulation in the elderly.
• Question 18
1 out of 1 points
A 14-year-old patient is prescribed Strattera and asks when the medicine
should be taken. What does the PMHNP understand regarding the drug’s dosing
profile?
Selected Answer: B.
The patient will have one or two doses a day.
• Question 19
1 out of 1 points The PMHNP is assessing a patient who presents with elevated
levels of brain amyloid as noted by positron emission tomography (PET). What
other factors will the PMHNP consider before prescribing medication for this
patient, and what medication would the PMHNP want to avoid given these
other factors?
Page 4 of 32
